Literature DB >> 28336330

Requirement of cytosolic phospholipase A2 gamma in lipid droplet formation.

Xi Su1, Shuhui Liu1, Xianwen Zhang1, Sin Man Lam2, Xue Hu3, Yuan Zhou3, Jizheng Chen3, Yun Wang3, Chunchen Wu3, Guanghou Shui2, Mengji Lu4, Rongjuan Pei5, Xinwen Chen6.   

Abstract

Lipid droplet (LD) accumulation in hepatocytes is a typical character of steatosis. Hepatitis C virus (HCV) infection, one of the risk factors related to steatosis, induced LD accumulation in cultured cells. However, the mechanisms of which HCV induce LD formation are not fully revealed. Previously we identified cytosolic phospholipase A2 gamma (PLA2G4C) as a host factor upregulated by HCV infection and involved in HCV replication. Here we further revealed that PLA2G4C plays an important role in LD biogenesis and refined the functional analysis of PLA2G4C in LD biogenesis and HCV assembly. LD formation upon fatty acid and HCV stimulation in PLA2G4C knockdown cells was impaired and could not be restored by complementation with PLA2G4A. PLA2G4C was tightly associated in the membrane with the domain around the amino acid residues 260-292, normally in ER but relocated into LDs upon oleate stimulation. Mutant PLA2G4C without enzymatic activity was not able to restore LD formation in PLA2G4C knockdown cells. Thus, both the membrane attachment and the enzymatic activity of PLA2G4C were required for its function in LD formation. The participation of PLA2G4C in LD formation is correlated with its involvement in HCV assembly. Finally, PLA2G4C overexpression itself led to LD formation in hepatic cells and enhanced LD accumulation in the liver of high-fat diet (HFD)-fed mice, suggesting its potential role in fatty liver disease.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Assemble; Cytosolic phospholipase A2 gamma; HCV; Lipid droplet; PLA2G4C; Steatosis

Mesh:

Substances:

Year:  2017        PMID: 28336330     DOI: 10.1016/j.bbalip.2017.03.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Biol Lipids        ISSN: 1388-1981            Impact factor:   4.698


  6 in total

1.  Histone Deacetylase 3 Inhibitor Suppresses Hepatitis C Virus Replication by Regulating Apo-A1 and LEAP-1 Expression.

Authors:  Yuan Zhou; Qian Wang; Qi Yang; Jielin Tang; Chonghui Xu; Dongwei Gai; Xinwen Chen; Jizheng Chen
Journal:  Virol Sin       Date:  2018-10-17       Impact factor: 4.327

2.  Enhanced host immune responses in presence of HCV facilitate HBV clearance in coinfection.

Authors:  Shuhui Liu; Kaitao Zhao; Xi Su; Xiaoxiao Gao; Yongxuan Yao; Ranran Kong; Yun Wang; Chunchen Wu; Mengji Lu; Xinwen Chen; Rongjuan Pei
Journal:  Virol Sin       Date:  2022-05-03       Impact factor: 6.947

Review 3.  Whole Lotta Lipids-from HCV RNA Replication to the Mature Viral Particle.

Authors:  Hanna Bley; Anja Schöbel; Eva Herker
Journal:  Int J Mol Sci       Date:  2020-04-21       Impact factor: 5.923

4.  The Effects of Naringenin on miRNA-mRNA Profiles in HepaRG Cells.

Authors:  Weiyang Fan; Rui Shi; Minyi Guan; Pan Chen; Hao Wu; Weiwei Su; Yonggang Wang; Peibo Li
Journal:  Int J Mol Sci       Date:  2021-02-25       Impact factor: 5.923

5.  Differentiating between liver diseases by applying multiclass machine learning approaches to transcriptomics of liver tissue or blood-based samples.

Authors:  Stanislav Listopad; Christophe Magnan; Aliya Asghar; Andrew Stolz; John A Tayek; Zhang-Xu Liu; Timothy R Morgan; Trina M Norden-Krichmar
Journal:  JHEP Rep       Date:  2022-08-18

Review 6.  Updating Phospholipase A2 Biology.

Authors:  Makoto Murakami; Hiroyasu Sato; Yoshitaka Taketomi
Journal:  Biomolecules       Date:  2020-10-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.